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Abstract
Background
Iron is a key pathogenic determinant of many infectious diseases. Hepcidin, the hormone
responsible for governing systemic iron homeostasis, is widely hypothesized to represent a
key component of nutritional immunity through regulating the accessibility of iron to invading
microorganisms during infection. However, the deployment of hepcidin in human bacterial
infections remains poorly characterized. Typhoid fever is a globally significant, human-
restricted bacterial infection, but understanding of its pathogenesis, especially during the
critical early phases, likewise is poorly understood. Here, we investigate alterations in hep-
cidin and iron/inflammatory indices following experimental human typhoid challenge.
Methodology/Principal Findings
Fifty study participants were challenged with Salmonella enterica serovar Typhi and moni-
tored for evidence of typhoid fever. Serum hepcidin, ferritin, serum iron parameters, C-reac-
tive protein (CRP), and plasma IL-6 and TNF-alpha concentrations were measured during
the 14 days following challenge. We found that hepcidin concentrations were markedly
higher during acute typhoid infection than at baseline. Hepcidin elevations mirrored the
kinetics of fever, and were accompanied by profound hypoferremia, increased CRP
and ferritin, despite only modest elevations in IL-6 and TNF-alpha in some individuals.
During inflammation, the extent of hepcidin upregulation associated with the degree of
hypoferremia.
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Conclusions/Significance
We demonstrate that strong hepcidin upregulation and hypoferremia, coincident with fever
and systemic inflammation, are hallmarks of the early innate response to acute typhoid
infection. We hypothesize that hepcidin-mediated iron redistribution into macrophages may
contribute to S. Typhi pathogenesis by increasing iron availability for macrophage-tropic
bacteria, and that targeting macrophage iron retention may represent a strategy for limiting
infections with macrophage-tropic pathogens such as S. Typhi.
Author Summary
An adequate supply of iron is essential for both human hosts and their infecting patho-
gens. Hepcidin is the human hormone that controls the quantity and distribution of iron
throughout the body. During infections, hepcidin activity may redistribute iron away from
serum and into macrophages, potentially affecting pathogen replication, depending on the
niche of the invading microbe. However, the involvement of hepcidin in human bacterial
infections remains poorly investigated. Similarly, the pathogenesis of typhoid fever, caused
by infection with Salmonella Typhi is also poorly understood. We therefore investigated
the behaviour of hepcidin and other iron/inflammation-related parameters during the
course of typhoid fever in human volunteers challenged experimentally with Salmonella
Typhi. Hepcidin concentrations rose rapidly during acute typhoid infection, in parallel
with fever. Hepcidin induction was accompanied by a rapid decline in serum iron concen-
trations, likely reflecting iron sequestration in macrophages (a preferred replication site of
Salmonella Typhi). The extent of hepcidin upregulation associated with the extent of
serum iron starvation. We hypothesize that hepcidin activity during acute typhoid infec-
tion in humans may elevate iron levels in the niche used by the pathogen for replication.
Targeting macrophage iron retention should be evaluated as a potential strategy for limit-
ing typhoid fever.
Introduction
Typhoid fever is a common infection that follows oral ingestion and invasion of the Gram-neg-
ative bacterium Salmonella enterica serovar Typhi (S. Typhi). An estimated 26.9 million cases
occurred globally in 2010, disproportionately affecting children in resource-limited areas of
sub-Saharan Africa and southeastern Asia [1,2].
S. Typhi is a human-restricted pathogen. Unlike non-typhoidal Salmonella infection, which
is characterized by rapid-onset gastrointestinal inflammation and diarrheal illness in immuno-
competent adults, S. Typhi causes a systemic infection. After ingestion, bacteria disseminate
through the reticuloendothelial system, where they are thought to incubate for 7–14 days. Clin-
ical illness then develops, characterized by fever and non-specific symptoms including head-
ache, nausea and abdominal pain, and accompanied by bacteremia [3]. However, detailed
understanding of typhoid pathogenesis remains limited, in part since convincing small-animal
infection models are lacking [4]. An experimental human S. Typhi challenge model was
recently reestablished, presenting a unique opportunity to investigate typhoid pathogenesis in
a controlled setting in the natural host [5–7].
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Conflict exists between hosts and invading pathogens over the control of the critical micro-
nutrient, iron (reviewed in [8,9]). To limit free iron availability, mammalian hosts sequester
iron using high-affinity iron-binding proteins including transferrin, lactoferrin, haptoglobin,
hemopexin and the iron storage protein ferritin. To counteract this, many bacteria express
higher affinity siderophores (e.g. enterobactin) that appropriate iron from host iron binding
proteins; host-produced siderophore-binding proteins such as lipocalin-2 in turn counter
these. A further host response to infection involves the rapid induction of hypoferremia, where
iron becomes sequestered in reticuloendothelial macrophages and therefore excluded from
serum [8,10]. This state may be disadvantageous to extracellular pathogens [11] but potentially
could be exploited by intracellular, macrophage-tropic bacteria including S. Typhi [12].
Together, the host mechanisms aimed at sequestering iron from invading microorganisms are
considered to contribute to innate protection against infection, often termed “nutritional
immunity” [8].
In recent years, many genes involved in mammalian iron homeostasis have been discovered
[13], meaning that the molecular basis of iron perturbations during infections can be investi-
gated in a new light. Amongst these, hepcidin stands out as the central regulator of systemic
iron balance [14]. Hepcidin dictates dietary iron uptake and recycling of red cell iron by bind-
ing and causing degradation of the sole known iron exporter ferroportin, which is expressed on
duodenal enterocytes and iron-recycling macrophages [15]. Consequently, high hepcidin levels
effect iron exclusion from serum, through blocking dietary iron uptake and preventing macro-
phage iron release. Hepcidin is induced homeostatically in response to increased plasma and
liver iron [16,17], but is also an acute phase protein upregulated by inflammatory cytokines,
notably IL-6 [18–20]. Thus, elevated hepcidin concentrations during inflammation and infec-
tions contribute to hypoferremia [11,21] and, if chronic, to iron-restricted erythropoiesis and
anemia [22].
Hepcidin regulation is less well studied in the context of human infection. Analyses to date
indicate that hepcidin behavior differs between infections. For example, it is upregulated dur-
ing uncomplicated malaria [23–26], and during acute, chronic and advanced HIV-1 infection
[27,28]; however, it is suppressed during Hepatitis C Virus infection [29], and in severe malar-
ial anemia, where bone-marrow derived signals indicating erythropoietic iron demand likely
dominate, suppressing hepcidin production [26,30]. Importantly, hepcidin remains remark-
ably poorly studied in human bacterial infections. This is despite iron representing a battle-
ground of host-bacterial conflict important enough to have shaped both primate and bacterial
genomes alike [31]. Here, we investigate the dynamics of hepcidin in relation to iron and
inflammatory indices during acute experimental Salmonella Typhi infection in humans.
Methods
Study participants
Human typhoid challenge was performed with healthy consenting adult volunteers (18–60
years) who had not previously received typhoid vaccination or resided in typhoid-endemic
areas for>6 months [7]. Data from two sets of study participants are described: first, from the
placebo arm of a vaccine/typhoid challenge study, where participants received an oral placebo
vaccine (sodium bicarbonate solution and excipients) 28 days before oral challenge with S.
Typhi (n = 30, Study A, Table 1 (baseline data from day of typhoid challenge shown)), and
secondly, for more detailed longitudinal analysis, from a previously described cohort chal-
lenged orally with S. Typhi in a preliminary dose-escalation challenge model (n = 20, Study B,
Table 1) [7].
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Typhoid challenge model
Full details of the challenge model used in both studies are described in Waddington et al [7].
Briefly, participants ingested a single freshly prepared dose of S. Typhi (Quailes strain, 104
CFU) suspended in sodium bicarbonate solution. After challenge, study participants were
reviewed daily for 14 days; blood samples were collected on alternate days, at typhoid diagnosis
and intervals thereafter. In typhoid-infected and non-infected participants, the mean blood
volumes collected during the 28 days following challenge were approximately 920mL and
600mL respectively. “Typhoid diagnosis” was defined a priori by clinical and/or microbiolog-
ical endpoints: temperature38°C sustained for12 hours and/or blood culture evidence of
S. Typhi bacteremia, respectively. Antibiotic treatment (ciprofloxacin, 500 mg twice daily, 14
days) was initiated upon attainment of either diagnostic criterion and in all remaining partici-
pants at Day 14. Actual challenge doses were determined, and quantitative blood culture was
performed at typhoid diagnosis, as previously described [7].
Quantification of hepcidin and other analytes
Serum samples were filtered prior to analyses using Costar Spin-X low protein binding 0.22μm
cellulose acetate membrane filters (Corning). Spin-filtering had no effect on hepcidin
Table 1. Baseline characteristics of study populations on the day of typhoid challenge.
Parameter Study A (placebo arm of vaccine/
challenge study)
Study B (challenge
study)
Number of participants 30 20
Age, median years (IQR) b 24.6 (21.7–39.4) 26.5 (23.4–38.4)
Male gender, n (%) b 18 (60) 12 (60)
Weight, median kg (IQR) b 75.9 (68.9–82) (n = 18) 79.4 (71.7–87.0)
(n = 15)
Height, median m (IQR) b 1.71 (1.67–1.82) NA
Challenge dose, mean Log10
a 4.27 (±0.07) 4.30 (±0.06)
Typhoid diagnosed, n (% of study) b 20 (66.6) 13 (65)
Days to typhoid diagnosis, median
number (range) b
7 (5–11) 8 (5–10)
Hemoglobin, b 14.1 (±1.6) 14.0 (±1.3)
Mean Corpuscular Volume (MCV), b 91.06 (± 4.61) 90.61 (±4.79)
Hematocrit, b 0.428 (±0.043) 0.428 (±0.037)
Platelets, b 248.5 (±64.9) 226.5 (± 38.9)
White cell count, b 6.2 (±1.8) 6.5 (±2.3)
Neutrophils, b 3.40 (±1.38) 3.59 (± 2.16)
Lymphocytes, b 2.01 (±0.65) 2.09 (± 0.59)
Eosinophils, b 0.21 (±0.11) 0.29 (± 0.15)
Serum Iron, μmol/L, b 12.3 (±5.6) 14.9 (±5.2)
Total Iron Binding Capacity (TIBC),
μmol/L a
56.3 (±7.2) 51.8 (±8.2)
Transferrin saturation (Tsat), %, a 22.3 (±10.6) 29.0 (±9.4)
Log10 ferritin, μg/L,
b 1.61 (0.38) 1.71 (0.37)
Log10 hepcidin, ng/mL,
b 1.01 (0.34) 1.1 (0.28)
Log10 CRP, mg/L
b 0.10 (±0.51) -0.29 (±0.57)
a p<0.05, t test
b p>0.05
c arithmetic mean (+/- standard deviation) reported unless stated otherwise.
doi:10.1371/journal.pntd.0004029.t001
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measurement (n = 4 samples, p = 0.36 (paired t-test)). Hepcidin was quantified by ELISA using
the hepcidin-25 EIA kit (Bachem), with the manufacturer’s protocol modified to incorporate a
9-point, 2-fold serial dilution standard curve. Samples were diluted to 10% or 5% prior to anal-
ysis. The lower limit of detection (LLOD) was 0.08 ng/mL, calculated as described previously
[27]. Samples returning a reading below LLOD were assigned the value (LLODdilution fac-
tor)/2.
Serum ferritin (Architect Ferritin Assay) was quantified using the Abbott Architect 2000R
automated analyzer (Abbott Laboratories); C-reactive protein (CRP) (MULTIGENT CRP
Vario Kit, with high sensitivity calibrators), serum iron and Unsaturated Iron Binding Capacity
(UIBC, MULTIGENT Iron Kit) were quantified using the Abbott Architect c16000 automated
analyzer (Abbott Laboratories). Transferrin saturation (Tsat) was calculated using the formula:
Tsat = ((Serum Iron)/(Serum Iron + Unsaturated Iron Binding Capacity))100. CRP concen-
trations above and below the assay limits of detection (160 and 0.1 mg/L) were assigned the val-
ues 160 mg/L and 0.05 mg/L respectively.
Plasma cytokine concentrations were measured in duplicate using a custom TNFα / IL-6
Luminex panel (MILLIPLEX MAP kit, Millipore) according to the manufacturer’s instructions.
Readings with % Coefficient of Variance>30% were excluded; those falling below the LLOD
were allocated the value 1.6 pg/mL (LLOD/2).
Hemoglobin, red blood cell counts, and mean corpuscular volume (MCV) were quantified
by routine hematologic analysis.
Statistical analysis
Statistical analyses were performed using Prism (version 6, GraphPad Software Inc.), SPSS
(version 16.0, IBM SPSS), STATA/SE13.1 (Statacorp) and R statistical language [32]. All raw
data can be found in the file S1 Dataset.
For indices that were not normally distributed (hepcidin, ferritin, and CRP in all cases; addi-
tionally serum iron and transferrin saturation when considering data other than baseline data),
geometric means were compared, or data were log-transformed prior to analysis. Differences
between indices pre-challenge and at typhoid diagnosis (Study A) were evaluated using paired
t-tests. In correlation analysis, Pearson correlation coefficients were computed; in cases where
study participants contributed more than a single observation, correlation analyses were
adjusted accordingly by using regression with clustered errors (STATA/SE13.1), which adjusts
the confidence intervals of the regression coefficients to account for intra-cluster correlation, as
is likely when multiple observations from the same individuals are included. Statistical tests
returning p<0.05 were considered significant.
Time-course analyses were performed using the packages fields [33], nlme [34] and lme4
[35] within R statistical language [32] as follows. (i) Normalization of time series: Since the time
between typhoid challenge and diagnosis (TD) varied between participants, the time variable
“day relative to TD” was used, with TD = 0 being day of diagnosis. (ii) Smoothing spline regres-
sion: Mean analyte measurements across all subjects for each day relative to TD were calcu-
lated; samples from day of typhoid challenge (‘baseline’) and the final visit (Day 14 post-
challenge) were grouped separately. A smoothing spline regression was applied with smooth-
ness estimated from the data by generalised cross validation (GCV) [36]. 95% pointwise pre-
diction intervals and conservative simultaneous Bonferroni bounds were calculated. (iii)
Assessment of the effect of time relative to TD on analyte concentrations: linear mixed-effects
models were fitted using a described model formulation [37] and computational framework
[38]. The categorical variable “day relative to TD” was modeled by fixed effects; variability
between individuals was captured using random effects. The null hypothesis that there is no
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significant difference in analyte levels over time after challenge was tested using the Wald test;
specific pairwise comparisons between analyte concentrations at baseline (day of challenge)
and later time-points were tested by t-tests, accounting for subject-specific variability. Tests
returning p<0.05 were considered significant.
Ethics
The National Research Ethics Service approved both studies (Oxfordshire Research Ethics
Committee A, 10/H0604/53 and 11/SC/0302). They were performed in accordance with the
principles of the ICH-Good Clinical Practice guidelines and amendments. All study partici-
pants provided written informed consent in accordance with the Declaration of Helsinki on at
least one occasion, as previously described [7].
Results
Baseline characteristics of study participants
Characteristics of study participants from two experimental typhoid challenge studies are
given in Table 1. The typhoid attack rates (percent typhoid-diagnosed participants by Day 14)
in Study A and B were 67% (20/30) and 65% (13/20), while mean duration between challenge
and typhoid diagnosis was 7.4 (95% Confidence Interval (CI): 6.6–8.3 days) and 7.7 days (6.7–
8.7 days), respectively. There were no significant differences in the baseline characteristics of
participants recruited to Study A or B, except that the challenge dose and transferrin satura-
tions were marginally higher in Study B. Considering all participants from Studies A and B
together, significant associations between log10-hepcidin and log10-ferritin levels (p<0.0001,
r2 = 0.642; S1 Fig, panel A) and between hepcidin and both transferrin saturation (S1 Fig, panel
B) and hemoglobin (S1 Fig, panel C) were found in baseline, pre-challenge samples. Male par-
ticipants had significantly higher baseline hemoglobin, hepcidin and ferritin levels than females
(S1 Fig, panels D-F). These observations are typical of healthy adult populations.
Effect of baseline characteristics on typhoid susceptibility
In univariate analyses, there were no significant differences in age, sex, weight or challenge
dose, or in baseline hematological or iron-related parameters between those subsequently diag-
nosed or not diagnosed with infection, even when participants from the two studies were
pooled together to increase power (S1 Table). Amongst individuals diagnosed with typhoid, we
found no association between the time to typhoid diagnosis and baseline iron status as indi-
cated by ferritin (r2 = 0.014, p = 0.505) or hepcidin (r2 = 0.015, p = 0.497). Amongst individuals
from the two studies who were diagnosed with typhoid, increasing challenge dose was signifi-
cantly negatively associated with time-to-diagnosis (r2 = 0.174, p = 0.016) and positively associ-
ated with the number of bacteria quantified at diagnosis (r2 = 0.241, p = 0.007).
Hepcidin is significantly elevated following typhoid diagnosis
To investigate the extent to which typhoid infection was associated with changes in hepcidin
and other iron indices, we analyzed serum samples collected at baseline and on day of typhoid
diagnosis in participants challenged in Study A (n = 19/20, 7 females and 12 males). Amongst
these individuals, the mean time to typhoid diagnosis was 7.4 days (95% CI: 6.6–8.3 days);
mean oral temperature was significantly higher at typhoid diagnosis than at baseline (diagno-
sis: 37.6°C [95% CI, 37.3–37.9°C]; baseline: 36.3°C [36.1–36.5°C]; Fig 1A).
Hepcidin concentrations at typhoid diagnosis were approximately 10-fold higher than at
baseline (Fig 1B). This marked hepcidin response was accompanied by hypoferremia
Hepcidin in Acute Human Typhoid Infection
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Fig 1. Changes in hepcidin, iron and inflammatory indices between baseline–the day of typhoid challenge–and the day of typhoid diagnosis.
Serum samples were available from both day of typhoid challenge and day of typhoid diagnosis from 19 individuals from Study A (placebo arm of vaccine/
typhoid challenge study). (A) temperature, (B) hepcidin, (C) serum iron, (D) transferrin saturation, (E) CRP, (F) ferritin and (G) hemoglobin were measured on
the day of challenge and day of typhoid diagnosis. P-values represent results of paired t tests based on geometric means for hepcidin (baseline, 10.4 ng/mL
[95% CI: 7.1–15.3]; diagnosis, 98.2 ng/mL [75.9–126.9]), ferritin (baseline, 46.3 μg/L [30.8–69.8]; diagnosis, 86.4μg/L [56.9–131.0]) and CRP (baseline: 1.46
mg/L [0.84–2.54]; diagnosis, 34.1 mg/L [24.2–48.2]), and arithmetic means for temperature (baseline, 36.3°C [36.1–36.5]; diagnosis, 37.6°C [37.3–37.9]),
Hepcidin in Acute Human Typhoid Infection
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demonstrated by a significant decline in mean serum iron and transferrin saturation (Fig 1C
and 1D). In contrast, there was a significant increase in the inflammatory markers, CRP and
ferritin at diagnosis compared to baseline, although the relative change in ferritin concentra-
tion was less notable than that of hepcidin or CRP (Fig 1E and 1F). There were no significant
differences in hemoglobin between measurements at baseline and at diagnosis (Fig 1G).
Together, these data demonstrate that significant hepcidin upregulation and concurrent hypo-
ferremia are features of the acute phase response to S. Typhi infection.
Kinetics of hepcidin and iron perturbations in typhoid-challenged
participants who did not develop infection
To assess the kinetics of alterations in hepcidin and other indices following S. Typhi challenge,
we analyzed serial samples from Study B, firstly from the 7 participants who did not develop
clinical disease following challenge, and secondly from the 13 individuals diagnosed with acute
infection. For both groups, up to 7 time points from Day 0 (baseline, challenge day) onwards
were analyzed (mean, 6.15 time points).
In those who did not develop typhoid infection, significant reductions in hepcidin, ferritin
and hemoglobin concentrations, and in red blood cell counts, were observed during the 14-day
study period (S2 Fig, panels A-D). There was also suggestion of decline in serum iron and
transferrin saturation (S2 Fig, panels E/F). This likely relates to the repeated phlebotomy
required by the study protocol, causing reduction of iron indices including hepcidin. CRP con-
centrations and oral temperatures remained low/normal throughout confirming the absence of
a systemic inflammatory response in challenged but non-infected individuals (S2 Fig, panels
G/H). Thus, the following time course data from typhoid-infected individuals must be inter-
preted in the light of these study protocol effects on hematological parameters.
Kinetics of hepcidin, iron and inflammatory perturbations during acute
typhoid fever
In participants who developed typhoid fever, increases in temperature were measured from 48
hours prior to diagnosis (Fig 2A). A concomitant rise in hepcidin concentration was observed,
maximal 2 days after diagnosis; temperature and hepcidin levels normalized towards baseline
levels over approximately 4 days following treatment initiation (Fig 2B). Similarly, significant
declines in serum iron (commencing prior to diagnosis and reaching a mean nadir of 4.9 μmol/
L two days post-diagnosis, down from 14.5 μmol/L at baseline, Fig 2C) and transferrin satura-
tion (mean 6% at nadir two days post-diagnosis, down from 28% at baseline, Fig 2D) were
observed; these indices, like hemoglobin (Fig 2E), were lower at the final time point (Day 14)
than at baseline (Fig 2C and 2D and 2E), likely reflecting the effect of venesection described
above (S2 Fig). However, the possibility of a hepcidin-mediated block in iron absorption during
infection contributing to this observation should not be excluded.
A significant induction of the acute phase protein CRP was also observed, escalating mar-
ginally later than the initial perturbations to hepcidin and transferrin saturation, but similarly
peaking 2 days after typhoid diagnosis (Fig 2F). The iron storage protein ferritin, also an acute
phase protein, was induced later than hepcidin or CRP and took longer to resolve towards
baseline levels (Fig 2G).
serum iron (baseline, 12.6 μmol/L [9.9–15.3]; diagnosis, 4.4 μmol/L [2.7–6.1]), transferrin saturation (baseline, 22.3% [17.2–27.4]; diagnosis, 7.4% [4.7–
10.2]) and hemoglobin (baseline, 14.3 g/dL [13.6–15.1]; diagnosis 13.9 g/dL [13.1–14.8]).
doi:10.1371/journal.pntd.0004029.g001
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Together, these data indicate that the kinetics of hepcidin perturbations and the associated
hypoferremia during acute S. Typhi infection mirror typhoid-associated fever and CRP
induction.
Contrary associations between hepcidin and iron parameters, according
to inflammation status
We next investigated relationships between hepcidin concentration and serum iron status in
those exhibiting typhoid-related inflammation and those who were not. In this analysis, we
included all data from the study from both diagnosed and non-diagnosed individuals, using
regression with clustered errors, thereby accounting for the inclusion of multiple observations
derived from the same individuals. When there was evidence of acute inflammation (defined as
CRP>5 mg/L), significant negative associations between hepcidin and both serum iron and
transferrin saturation were observed (Fig 3A and 3B). In contrast, when acute inflammation
was absent (CRP<5 mg/L), significant positive associations between hepcidin and serum iron
parameters were found (Fig 3A and 3B). Thus, larger hepcidin responses predicted more pro-
found hypoferremia in the context of inflammation, but the opposite in non-inflamed samples,
when they presumably reflected iron status. The latter effect was also noted in baseline chal-
lenge day samples (S1 Fig). Unlike hepcidin, ferritin did not correlate with the extent of hypo-
ferremia during inflammation, although it did associate positively with serum iron parameters
in non-inflamed samples (Fig 3C and 3D). These data indicate non-equivalence of these two
indices of iron status, as noted in previous work [39], and suggest hepcidin may be more closely
linked to hypoferremia in the context of the acute inflammation observed during typhoid
infection.
Modest induction of inflammatory cytokines in individuals with typhoid
infection
Hepcidin upregulation during acute phase responses is typically associated with STAT3 activa-
tion following signaling by IL-6 and potentially other cytokines (e.g. IL-22) [18–20]. We there-
fore assessed IL-6 concentrations in plasma samples from the individuals from Study B who
developed typhoid infection. We only observed a weak IL-6 response in a subset of individuals
(Fig 4A, see S3 Fig for individual profiles); in the majority of individuals, IL-6 upregulation was
not detected. Modest TNF-alpha responses were more consistent, with the highest levels
recorded day 2 post-diagnosis in most individuals (Fig 4B, see S3 Fig for individual profiles).
These data suggest the cytokine response during typhoid infection may have been blunted, as
Fig 2. Kinetics of perturbations in hepcidin, iron and inflammatory parameters in individuals diagnosed with typhoid infection following
experimental Salmonella Typhi challenge. (A) Temperatures, (B) serum hepcidin concentrations, (C) serum iron, (D) transferrin saturations, (E)
hemoglobin, (F) CRP, and (G) ferritin concentrations were measured in 13 individuals from Study B who received typhoid diagnosis following challenge with
Salmonella Typhi. Analyte values are plotted relative to the day of typhoid diagnosis, TD = day 0; since not all individuals were diagnosed on the same day
post-challenge, baseline samples from the day of challenge (Chall) are considered together, as are data from the final day 14 visit (Final). (Left-hand panels)
Data available from each individual for each day were plotted using box and whiskers, representing median values and interquartile ranges (IQR); whiskers
represent the data point occurring furthest from the first or third quartile but still within 1.5*IQR of the quartile; outliers (further than 1.5*IQR from the quartile)
are shown as isolated data points. Smoothed curves were also interpolated from the mean data for each day and overlaid on the plots. TheWald test was
employed after fitting linear mixed effects models to test the null hypothesis that there is no difference between parameter values between days. Pairwise
differences between baseline values on the day of typhoid challenge (Chall) and other days were examined by t-tests after accounting for subject-specific
variability. Significant perturbations from baseline are indicated with asterisks (*p<0.05, **p<0.01, ***p<0.001). For ferritin, outliers at (a) 1014.07 μg/L and
1075.24 μg/L, (b) 2433.54 μg/L, and (c) 1008.87 μg/L are beyond the y-axis limits and not depicted on the figure, but are included in the analysis. (Right-hand
panels) Smoothed interpolated curves as described above, but depicting 95% pointwise prediction intervals (thick error bar) and conservative simultaneous
Bonferroni bounds (thin error bar) of the interpolated curves.
doi:10.1371/journal.pntd.0004029.g002
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previously described [40], and that determinants other than serum IL-6 may be responsible for
the hepcidin upregulation observed in this context.
Discussion
Salmonella Typhi is a significant human pathogen, leading to a major global burden of disease
particularly among children and younger adults in endemic settings [1,2]. Evolution from a
common Salmonella ancestor is thought to have occurred ~50–100,000 years ago [41]. How-
ever, the basis for the evolution of its ability to evade host defenses and cause systemic infection
remains poorly characterized. Understanding how S. Typhi interacts with the human host
environment, including the macrophage niche, is crucial in deciphering its pathogenicity and
for devising prevention or eradication strategies. The battle for iron is a key determinant of
host-bacterial interactions [8,9,31]. Here, using an experimental human typhoid challenge
model, we track for the first time in an invasive human bacterial infection the behavior of the
Fig 3. Opposite associations of hepcidin with serum iron and transferrin saturation in the presence and absence of inflammation. Associations
between (A) hepcidin and serum iron, (B) hepcidin and transferrin saturation (Tsat), (C) ferritin and serum iron, and (D) ferritin and Tsat, when acute
inflammation (defined as CRP>5 mg/L, open circles) or when no inflammation (CRP<5 mg/L, closed circles) was evident. The analysis considered all data
obtained between challenge day and Day 14 post-challenge for each study participant, whether diagnosed with typhoid or not. To normalize data, each
parameter was log-transformed prior to analysis. The analysis accounts for individuals contributing more than single data points by using regression with
clustered errors (Serum Iron analyses (A) and (C): CRP <5 mg/L: 118 observations, 47 clusters; CRP >5 mg/L: 69 observations, 36 clusters. Tsat analyses
(B) and (D): CRP <5 mg/L: 117 observations, 46 clusters; CRP >5 mg/L: 69 observations, 36 clusters). Regression with clustered errors adjusts the
confidence intervals of the regression coefficients to account for intra-cluster correlation, as is likely when multiple observations from the same individuals are
included. Pearson correlation coefficients and p-values are stated.
doi:10.1371/journal.pntd.0004029.g003
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iron regulatory hormone hepcidin and its relationship to perturbations in iron parameters,
inflammatory markers, and fever: significant hepcidin upregulation, accompanied by a pro-
found decline in serum iron was observed in participants diagnosed with typhoid infection.
Hepcidin has several characteristics reflecting a likely ancestry in immunity to infection. It
is a liver-derived acute-phase peptide induced via the inflammatory JAK/STAT3 signaling
pathway [18–20,42]. It structurally resembles antimicrobial beta-defensins and has modest
Fig 4. Kinetics of perturbations in IL-6 and TNF-alpha in individuals diagnosed with typhoid infection
following experimental Salmonella Typhi challenge. (A) Plasma IL-6 and (B) TNF-alpha concentrations
were measured in 13 individuals from Study B who received typhoid diagnosis following challenge with
Salmonella Typhi. Analyte values are plotted relative to the day of typhoid diagnosis, TD = day 0; since not all
individuals were diagnosed on the same day post-challenge, baseline samples from the day of challenge
(Chall) are considered together, as are data from the final day 14 visit (Final). (Left-hand panels) Data
available from each individual for each day were plotted using box and whiskers, representing median values
and interquartile ranges (IQR); whiskers represent the data point occurring furthest from the first or third
quartile but still within 1.5*IQR of the quartile; outliers (further than 1.5*IQR from the quartile) are shown as
isolated data points. Smoothed curves were also interpolated from the mean data for each day and overlaid
on the plots. TheWald test was employed after fitting linear mixed effects models to test the null hypothesis
that there is no difference between parameter values between days. Pairwise differences between baseline
values on the day of typhoid challenge (Chall) and other days were examined by t-tests after accounting for
subject-specific variability. Significant perturbations from baseline are indicated with asterisks (***p<0.001).
(Right-hand panels) Smoothed interpolated curves as described above, but depicting 95% pointwise
prediction intervals (thick error bar) and conservative simultaneous Bonferroni bounds (thin error bar) of the
interpolated curves.
doi:10.1371/journal.pntd.0004029.g004
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antimicrobial activity itself [43,44]. Hepcidin’s involvement in human infection pathogenesis
has been widely proposed, likely relating more to its ability to rapidly alter systemic partition-
ing of iron than its direct antimicrobial activity [12]. Despite this, its regulation and influence
on the pathogenesis of human bacterial infection remains poorly investigated. In humans, sig-
nificant hepcidin upregulation has been observed during sepsis [45,46], during tuberculosis
(with and without HIV coinfection) [47,48], and to a less notable extent in children with con-
current Helicobacter pylori infection and iron deficiency anemia [49]. The longitudinal behav-
ior of hepcidin has been assessed during experimental uncomplicated malaria (where modest
increases in hepcidin and IL-6, associated with changes in systemic iron parameters, were
observed) [23] and during the acute phases of HIV-1, Hepatitis B Virus and Hepatitis C Virus
infections [27]. However, the nature of longitudinal perturbations in hepcidin during the acute
phase of a bacterial infection in humans has never been investigated.
In study participants diagnosed with acute typhoid infection, we found a marked upregula-
tion of hepcidin around the time of diagnosis, coincident with appearance of fever. Hepcidin
concentrations remained high for at least 48-hours during acute infection irrespective of
prompt antibiotic therapy, and resolved to normal levels from 4 days after diagnosis. We pre-
dict that hepcidin would remain high for considerably longer if the infection were left
untreated. Significant elevations in the acute phase proteins, CRP and ferritin, and striking
declines in serum iron and transferrin saturation (from 28% at baseline to 6% at nadir 2 days
post-diagnosis) were also evident. The data suggested hepcidin activity from 1–2 days prior to
typhoid diagnosis, and are consistent with the previous description of hypoferremia in the
Maryland typhoid challenge in the 1970s [50]. Furthermore, our data indicated that, when
acute inflammation was present, the extent of hepcidin upregulation significantly predicted the
degree of hypoferremia; in contrast, in normal non-inflamed conditions, hepcidin positively
associated with serum iron parameters. Given these data, hepcidin and the associated hypofer-
remia should be considered for investigation as potential biomarkers of acute infection.
Hepcidin upregulation in the context of inflammation/infection is typically linked to signal-
ing via the IL-6/STAT3 pathway [19,42]. However, we only detected a modest elevation in
plasma IL-6 around typhoid diagnosis, with several participants maintaining IL-6 levels below
detectable levels at each sampling time point. When IL-6 was detected, it was at considerably
lower levels than in other conditions where hepcidin is notably induced: IL-6 was typically one
or more orders of magnitude higher during uncomplicated malaria [24], sepsis [45], or experi-
mental endotoxemia [21]. Similarly, although TNF-alpha was induced, the levels detected were
relatively low. Since IL-6 and TNF-alpha data were not available from the day of diagnosis or
the following day, we cannot exclude the occurrence of a stronger, transient IL-6 induction
during these two days. Similarly, we cannot exclude more local but significant cytokine effects
in intestine, portal circulation and liver leading to hepcidin upregulation that may not be
detected in systemic circulation. Nevertheless, one established feature of S. Typhi infection is a
blunted cytokine response [40]. Several factors, most prominently the Vi-capsular polysaccha-
ride, enable S. Typhi to evade innate immune responses (for example by enabling evasion of
detection by complement [51]) and to establish systemic infections without clinical sepsis
[40,52]. It is therefore possible signals besides IL-6 are involved in the significant acute phase
response and hepcidin induction during acute typhoid infection. Thus, despite being an immu-
nologically evasive infection, dramatic hepcidin up-regulation and hypoferremia remain fea-
tures of typhoid in humans. Mechanistic links between hepcidin and hypoferremia should not,
however, be concluded from observational data such as these. Nevertheless, based on data from
other settings linking hypoferremia with hepcidin upregulation during infection and inflam-
mation [11,53], we hypothesize that hepcidin plays a role in mediating hypoferremia and that
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the hypoferremia reflects rapid sequestration of iron in macrophages during acute typhoid
infection.
The interplay between Salmonella enterica infection and iron has been well studied, typically
through using in vitro or in vivo S. Typhimurium models. The iron exporter ferroportin is
upregulated via NO-mediated Nrf2 activation in ex vivo S. Typhimurium-infected macro-
phages, reducing macrophage iron availability—a state that restricts bacterial replication [54–
56]. Despite this mechanism, hepcidin induction and hypoferremia are still observed during
invasive murine S. Typhimurium infection, associating with macrophage iron sequestration via
reduced ferroportin activity; interference with hepcidin upregulation in this context, leading to
reduced cellular iron levels, is protective for the host [55]. Correspondingly, hepcidin adminis-
tration to infected ferroportin-expressing cells in vitro enhances bacterial replication [54].
As reflected by their different pathologies, there are key differences between non-typhoidal
and typhoidal Salmonella enterica serovars, despite high degrees of sequence homology [57].
These include the expression of virulence determinants (most notably the Vi-capsular antigen)
and inactivation of over 200 genes in S. Typhi compared with its cousin S. Typhimurium [57].
Interestingly, several of these inactivated genes relate to iron acquisition pathways [58]. There
is evidence that S. Typhi relies heavily on the fepBDCG enterobactin ferric iron uptake system
[57], which is upregulated in isolates from typhoid patients [59]; the upregulation of this sys-
tem likely reflects the difficulty of obtaining iron from a host environment where iron availabil-
ity is typically scarce.
In conclusion, during human S. Typhi infection, where hepcidin is strongly upregulated and
a marked hypoferremia is observed, we hypothesize that hepcidin activity and macrophage
iron retention are dominant over any macrophage cell-intrinsic protective mechanisms aimed
at reducing cellular iron content. Stimulating a strong hepcidin response may represent
another bacterial strategy for ensuring iron supply to facilitate replication. Therefore, in
typhoid (and possibly other macrophage-tropic intracellular bacterial infections), hepcidin-
induced hypoferremia may be actively disadvantageous to the host rather than being a stereo-
typical protective response to infection [11]. A recent study in humans demonstrated that spie-
gelmer-based hepcidin neutralization during experimental endotoxemia can prevent induction
of hypoferremia [53]. Whether targeted manipulation of hepcidin and host iron distribution
offers a potential strategy for treating intracellular infections should be investigated further,
particularly in an era of increasing antibiotic resistance.
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infection. Analyte values are plotted relative to the day of typhoid challenge, day 0. (Left-hand
panels) Data available from each individual for each day were plotted using box and whiskers,
representing median values and interquartile ranges (IQR); whiskers represent the datapoint
occurring furthest from the first or third quartile but still within 1.5IQR of the quartile; outli-
ers (further than 1.5IQR from the quartile) are shown as isolated datapoints. Smoothed curves
were also interpolated from the mean data for each day and overlaid on the plots. The Wald
test was employed after fitting linear mixed effects models to test the null hypothesis that there
is no difference between parameter values between days. Pairwise differences between baseline
(day of typhoid challenge) values and other days were examined by t-tests after accounting for
subject-specific variability. Significant perturbations from baseline are indicated with asterisks
(p<0.05, p<0.001). (Right-hand panels) Smoothed interpolated curves as described above,
but depicting 95% pointwise prediction intervals (thick error bar) and conservative simulta-
neous Bonferroni bounds (thin error bar) of the interpolated curves.
(EPS)
S3 Fig. Individual timecourses depicting changes in plasma IL-6 and TNF-alpha concentra-
tions following S. Typhi challenge. Data are plotted relative to the day of typhoid diagnosis.
(EPS)
S1 Dataset. Raw data.
(XLSX)
Acknowledgments
We would like to thank the study participants and volunteers.
Author Contributions
Conceived and designed the experiments: TCD CJB HD AJP AEA. Performed the experiments:
TCD CSW CJB CJ PS AEA. Analyzed the data: TCD CJB EG AEA. Contributed reagents/mate-
rials/analysis tools: CW. Wrote the paper: TCD CJB HD AEA.
References
1. Buckle GC, Walker CL, Black RE (2012) Typhoid fever and paratyphoid fever: Systematic review to
estimate global morbidity and mortality for 2010. J Glob Health 2: 010401. doi: 10.7189/jogh.02.
010401 PMID: 23198130
2. Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82:
346–353. PMID: 15298225
3. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ (2002) Typhoid fever. N Engl J Med 347: 1770–
1782. PMID: 12456854
4. Strugnell RA, Scott TA, Wang N, Yang C, Peres N, et al. (2014) Salmonella vaccines: lessons from the
mouse model or bad teaching? Curr Opin Microbiol 17: 99–105. doi: 10.1016/j.mib.2013.12.004 PMID:
24440968
5. Darton TC, Blohmke CJ, Pollard AJ (2014) Typhoid epidemiology, diagnostics and the human chal-
lenge model. Curr Opin Gastroenterol 30: 7–17. doi: 10.1097/MOG.0000000000000021 PMID:
24304980
6. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, et al. (1970) Typhoid fever: patho-
genesis and immunologic control. N Engl J Med 283: 686–691. PMID: 4916913
7. Waddington CS, Darton TC, Jones C, Haworth K, Peters A, et al. (2014) An outpatient, ambulant-
design, controlled human infection model using escalating doses of Salmonella Typhi challenge deliv-
ered in sodium bicarbonate solution. Clin Infect Dis 58: 1230–1240. doi: 10.1093/cid/ciu078 PMID:
24519873
Hepcidin in Acute Human Typhoid Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004029 September 22, 2015 15 / 18
8. Ganz T (2009) Iron in innate immunity: starve the invaders. Curr Opin Immunol 21: 63–67. doi: 10.
1016/j.coi.2009.01.011 PMID: 19231148
9. Hood MI, Skaar EP (2012) Nutritional immunity: transition metals at the pathogen-host interface. Nat
Rev Microbiol 10: 525–537. doi: 10.1038/nrmicro2836 PMID: 22796883
10. Cartwright GE, Lauritsen MA, Jones PJ, Merrill IM, Wintrobe MM (1946) The Anemia of Infection. I.
Hypoferremia, Hypercupremia, and Alterations in Porphyrin Metabolism in Patients. J Clin Invest 25:
65–80.
11. Arezes J, Jung G, Gabayan V, Valore E, Ruchala P, et al. (2015) Hepcidin-Induced Hypoferremia Is a
Critical Host Defense Mechanism against the Siderophilic Bacterium Vibrio vulnificus. Cell Host
Microbe 17: 47–57. doi: 10.1016/j.chom.2014.12.001 PMID: 25590758
12. Drakesmith H, Prentice AM (2012) Hepcidin and the iron-infection axis. Science 338: 768–772. doi: 10.
1126/science.1224577 PMID: 23139325
13. Andrews NC (2008) Forging a field: the golden age of iron biology. Blood 112: 219–230. doi: 10.1182/
blood-2007-12-077388 PMID: 18606887
14. Ganz T (2013) Systemic iron homeostasis. Physiol Rev 93: 1721–1741. doi: 10.1152/physrev.00008.
2013 PMID: 24137020
15. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004) Hepcidin regulates cellular
iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090–2093. PMID:
15514116
16. Corradini E, Meynard D, WuQ, Chen S, Ventura P, et al. (2011) Serum and liver iron differently regulate
the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54: 273–284.
doi: 10.1002/hep.24359 PMID: 21488083
17. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, et al. (2007) Iron transferrin regulates hepci-
din synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110: 2182–2189.
PMID: 17540841
18. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, et al. (2011) Hepcidin regulation by
innate immune and infectious stimuli. Blood 118: 4129–4139. doi: 10.1182/blood-2011-04-351957
PMID: 21873546
19. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, et al. (2004) IL-6 mediates hypoferremia of
inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:
1271–1276. PMID: 15124018
20. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, et al. (2003) Hepcidin, a putative mediator
of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461–2463. PMID: 12433676
21. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D (2005) Time-course analysis of hepci-
din, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106: 1864–1866.
PMID: 15886319
22. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, et al. (2010) Antihepcidin antibody treatment
modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood
115: 3616–3624. doi: 10.1182/blood-2009-09-245977 PMID: 20053755
23. de Mast Q, van Dongen-Lases EC, Swinkels DW, Nieman AE, Roestenberg M, et al. (2009) Mild
increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin
during an experimental humanmalaria infection. Br J Haematol 145: 657–664. doi: 10.1111/j.1365-
2141.2009.07664.x PMID: 19344417
24. de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, et al. (2009) Assessment of urinary concentra-
tions of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection.
J Infect Dis 199: 253–262. doi: 10.1086/595790 PMID: 19032104
25. Howard CT, McKakpo US, Quakyi IA, Bosompem KM, Addison EA, et al. (2007) Relationship of hepci-
din with parasitemia and anemia among patients with uncomplicated Plasmodium falciparummalaria in
Ghana. Am J Trop Med Hyg 77: 623–626. PMID: 17978060
26. Casals-Pascual C, Huang H, Lakhal-Littleton S, Thezenas ML, Kai O, et al. (2012) Hepcidin demon-
strates a biphasic association with anemia in acute Plasmodium falciparummalaria. Haematologica
97: 1695–1698. doi: 10.3324/haematol.2012.065854 PMID: 22689680
27. Armitage AE, Stacey AR, Giannoulatou E, Marshall E, Sturges P, et al. (2014) Distinct patterns of hep-
cidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci U S A.
28. Wisaksana R, de Mast Q, Alisjahbana B, Jusuf H, Sudjana P, et al. (2013) Inverse relationship of
serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian pro-
spective cohort study. PLoS One 8: e79904. doi: 10.1371/journal.pone.0079904 PMID: 24244576
Hepcidin in Acute Human Typhoid Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004029 September 22, 2015 16 / 18
29. Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, et al. (2009) Reduced serum hepcidin levels
in patients with chronic hepatitis C. J Hepatol 51: 845–852. doi: 10.1016/j.jhep.2009.06.027 PMID:
19729219
30. Jonker FA, Calis JC, Phiri K, Kraaijenhagen RJ, Brabin BJ, et al. (2013) Low hepcidin levels in severely
anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency.
PLoS One 8: e78964. doi: 10.1371/journal.pone.0078964 PMID: 24339866
31. Barber MF, Elde NC (2014) Nutritional immunity. Escape from bacterial iron piracy through rapid evolu-
tion of transferrin. Science 346: 1362–1366. doi: 10.1126/science.1259329 PMID: 25504720
32. R-Core-Team (2013) R: A Language and Environment for Statistical Computing. R Foundation for Sta-
tistical Computing.
33. Furrer R, Nychka D, Stephen S (2013) fields: Tools for spatial data. R Package version 6.8.
34. Pinheiro J, Bates DM, DebRoy S, Sarkar D (2013) nlme: Linear and Nonlinear Mixed Effects Models. R
package version 3.1–111.
35. Bates D, Maechler M, Bolker B, Walker S (2013) lme4: Linear mixed-effects models using Eigen and
S4. R package version 1.0–4.
36. Craven P, GraceW (1978) Smoothing noisy data with spline functions. Numerische Mathematik 31:
377–403.
37. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38: 963–974.
PMID: 7168798
38. LindstromMJ, Bates DM (1988) Newton-Raphson and Em Algorithms for Linear Mixed-Effects Models
for Repeated-Measures Data. Journal of the American Statistical Association 83: 1014–1022.
39. Pasricha SR, Atkinson SH, Armitage AE, Khandwala S, Veenemans J, et al. (2014) Expression of the
iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med 6:
235re233.
40. Raffatellu M, Chessa D, Wilson RP, Tukel C, Akcelik M, et al. (2006) Capsule-mediated immune eva-
sion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun 74: 19–27.
PMID: 16368953
41. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, et al. (2006) Evolutionary history of Salmonella
typhi. Science 314: 1301–1304. PMID: 17124322
42. Wrighting DM, Andrews NC (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood
108: 3204–3209. PMID: 16835372
43. Krause A, Neitz S, Magert HJ, Schulz A, ForssmannWG, et al. (2000) LEAP-1, a novel highly disulfide-
bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480: 147–150. PMID: 11034317
44. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in
the liver. J Biol Chem 276: 7806–7810. PMID: 11113131
45. van Eijk LT, Kroot JJ, TrompM, van der Hoeven JG, Swinkels DW, et al. (2011) Inflammation-induced
hepcidin-25 is associated with the development of anemia in septic patients: an observational study.
Crit Care 15: R9. doi: 10.1186/cc9408 PMID: 21219610
46. Wu TW, Tabangin M, Kusano R, Ma Y, Ridsdale R, et al. (2013) The utility of serum hepcidin as a bio-
marker for late-onset neonatal sepsis. J Pediatr 162: 67–71. doi: 10.1016/j.jpeds.2012.06.010 PMID:
22796049
47. Kerkhoff AD, Meintjes G, Burton R, Vogt M, Wood R, et al. (2015) Relationship between blood concen-
trations of hepcidin and anaemia severity, mycobacterial burden and mortality in patients with HIV-
associated tuberculosis. J Infect Dis.
48. Minchella PA, Donkor S, Owolabi O, Sutherland JS, McDermid JM (2015) Complex anemia in tubercu-
losis: the need to consider causes and timing when designing interventions. Clin Infect Dis 60: 764–
772. doi: 10.1093/cid/ciu945 PMID: 25428413
49. Azab SF, Esh AM (2013) Serum hepcidin levels in Helicobacter pylori-infected children with iron-defi-
ciency anemia: a case-control study. Ann Hematol 92: 1477–1483. doi: 10.1007/s00277-013-1813-2
PMID: 23760782
50. Pekarek RS, Kluge RM, DuPont HL, Wannemacher RW Jr., Hornick RB, et al. (1975) Serum zinc, iron,
and copper concentrations during typhoid fever in man: effect of chloramphenicol therapy. Clin Chem
21: 528–532. PMID: 1090399
51. Wilson RP, Winter SE, Spees AM,Winter MG, Nishimori JH, et al. (2011) The Vi capsular polysaccha-
ride prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi. Infect
Immun 79: 830–837. doi: 10.1128/IAI.00961-10 PMID: 21098104
52. Tsolis RM, Young GM, Solnick JV, Baumler AJ (2008) From bench to bedside: stealth of enteroinvasive
pathogens. Nat Rev Microbiol 6: 883–892. doi: 10.1038/nrmicro2012 PMID: 18955984
Hepcidin in Acute Human Typhoid Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004029 September 22, 2015 17 / 18
53. van Eijk LT, John AS, Schwoebel F, Summo L, Vauleon S, et al. (2014) Effect of the anti-hepcidin Spie-
gelmer(R) lexaptepid on inflammation-induced decrease in serum iron in humans. Blood 124: 2643–
2646. doi: 10.1182/blood-2014-03-559484 PMID: 25163699
54. Chlosta S, Fishman DS, Harrington L, Johnson EE, Knutson MD, et al. (2006) The iron efflux protein
ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun 74: 3065–3067.
PMID: 16622252
55. Kim DK, Jeong JH, Lee JM, Kim KS, Park SH, et al. (2014) Inverse agonist of estrogen-related receptor
gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med 20:
419–424. doi: 10.1038/nm.3483 PMID: 24658075
56. Nairz M, Schleicher U, Schroll A, Sonnweber T, Theurl I, et al. (2013) Nitric oxide-mediated regulation
of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J
Exp Med 210: 855–873. doi: 10.1084/jem.20121946 PMID: 23630227
57. Barquist L, Langridge GC, Turner DJ, Phan MD, Turner AK, et al. (2013) A comparison of dense trans-
poson insertion libraries in the Salmonella serovars Typhi and Typhimurium. Nucleic Acids Res 41:
4549–4564. doi: 10.1093/nar/gkt148 PMID: 23470992
58. McClelland M, Sanderson KE, Clifton SW, Latreille P, Porwollik S, et al. (2004) Comparison of genome
degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause
typhoid. Nat Genet 36: 1268–1274. PMID: 15531882
59. Sheikh A, Charles RC, Sharmeen N, Rollins SM, Harris JB, et al. (2011) In vivo expression of Salmo-
nella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh. PLoS
Negl Trop Dis 5: e1419. doi: 10.1371/journal.pntd.0001419 PMID: 22180799
Hepcidin in Acute Human Typhoid Infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004029 September 22, 2015 18 / 18
